About: The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
Creator	Amato, Maria Brichetto, Giampaolo Chataway, Jeremy Chiaravalloti, Nancy Dalgas, Ulrik Filippi, · Freeman, Jennifer Meza, Cecilia Moore, Nancy Deluca, · Feys, ·
Source	Medline; PMC
abstract	OBJECTIVE: Individuals with pre-existing chronic illness have shown increased anxiety and depression due to COVID-19. Here, we examine the impact of the COVID-19 pandemic on emotional symptomatology and quality of life in individuals with Progressive Multiple Sclerosis (PMS). METHODS: Data were obtained during a randomized clinical trial on rehabilitation taking place at 11 centers in North America and Europe. Participants included 131 individuals with PMS. Study procedures were interrupted in accordance with governmental restrictions as COVID-19 spread. During study closure, a COVID Impact Survey was administered via telephone or email to all participants, along with measures of depressive symptoms, anxiety symptoms, quality of life, and MS symptomatology that were previously administered pre-pandemic. RESULTS: 4% of respondents reported COVID-19 infection. No significant changes were noted in anxiety, quality of life, or the impact of MS symptomatology on daily life from baseline to lockdown. While total HADS-depression scores increased significantly at follow-up, this did not translate into more participants scoring above the HADS threshold for clinically significant depression. No significant relationships were noted between disease duration, processing speed ability or EDSS, and changes in symptoms of depression or anxiety. Most participants reported the impact of the virus on their psychological well-being, with a little impact on financial well-being. The perceived impact of the pandemic on physical and psychological well-being was correlated with the impact of MS symptomatology on daily life, as well as changes in depression. CONCLUSIONS: Overall, little change was noted in symptoms of depression or anxiety or overall quality of life.
has issue date	2020-08-19(xsd:dateTime)
bibo:doi	10.1007/s00415-020-10160-7
bibo:pmid	32813051
has license	no-cc
sha1sum (hex)	f79c02f722ec25cb5cb060e71a917e19341ce651
schema:url	https://doi.org/10.1007/s00415-020-10160-7
resource representing a document's title	The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
has PubMed Central identifier	PMC7436067
has PubMed identifier	32813051
schema:publication	J Neurol
resource representing a document's body	covid:f79c02f722ec25cb5cb060e71a917e19341ce651#body_text
is schema:about of	named entity 'threshold' named entity 'randomized clinical trial' named entity 'symptomatology' named entity 'life' named entity 'psychological well-being' named entity 'Impact' named entity 'While' named entity 'COVID-19' named entity 'ABILITY' named entity 'EUROPE' named entity 'pandemic' named entity 'telephone' named entity 'depression' named entity 'disease' named entity 'life' named entity 'procedures' named entity 'individuals' named entity 'Europe' named entity 'North America' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'chronic illness' named entity 'depression' named entity 'PMS' named entity 'psychological well-being' named entity 'Progressive Multiple Sclerosis' named entity 'quality of life' named entity 'quality of life' named entity 'March 11' named entity 'PMS' named entity 'anxiety' named entity 'study protocol' named entity 'Progressive Multiple Sclerosis' named entity 'psychological well-being' named entity 'PMS' named entity 'anxiety' named entity 'symptomology' named entity 'infectious diseases' named entity 'depressive symptoms' named entity 'COVID-19 pandemic' named entity 'physical well-being' named entity 'depression' named entity 'depression' named entity '13.5' named entity 'depression' named entity 'virus' named entity 'symptomatology' named entity 'neuropsychiatric' named entity 'psychological well-being' named entity 'RCT' named entity 'general population' named entity 'anxiety' named entity 'Novartis' named entity 'mental scale' named entity 'depression' named entity 'COVID-19' named entity 'symptomatology' named entity 'depression' named entity 'Cognitive Rehabilitation' named entity 'general population' named entity 'COVID-19' named entity 'depression' named entity 'depression' named entity 'physical disability' named entity 'neurological impairment' named entity 'depressive symptoms' named entity 'anxiety' named entity 'demographic data' named entity 'general population' named entity 'depression' named entity 'Depressive symptoms'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software